UNSPSC 51384627: Metamizole sodium

This classification denotes an anti-inflammatory agents, non-steroidal, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VSU62Z74ON. European Medicines Agency schedules Metamizole sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08810MIG. Metamizole sodium generally arises in the molecular formula C13H16N3O4S.NA. The term METAMIZOLE SODIUM is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule metamizole sodium under HS 29331190.

As of Q4 2014, METAMIZOLE SODIUM remains US FDA's Preferred Term for this commodity. SMILES: CC1C(C(=O)N(N1C)C2CCCCC2)N(C)CS(=O)(=O)[O-].[NA+].

UNSPSC 51384627 Metamizole sodium is a Commodity code that, based on recent state and local procurement activity, does not align with the code's pharmaceutical scope. The single recent opportunity tagged to this code is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, which solicits naloxone and drug deactivation systems—products unrelated to metamizole sodium, an antipyretic and analgesic medication. The mismatch between the code's nominal scope and the actual procurement signals that this code shows little relevant recent activity in state and local procurement under its stated definition. Metamizole sodium procurement, if it occurs in the state and local market, is not currently surfaced in publicly posted solicitations.

Absent recent opportunities aligned with the code's actual pharmaceutical category, no issuing-body pattern, geographic concentration, or representative recent solicitations in metamizole sodium can be characterized. Business development professionals evaluating activity under this code should verify whether state and local agencies are procuring metamizole sodium through other UNSPSC codes, cooperative purchasing agreements, or standing healthcare-system contracts that do not trigger individual public solicitations.